The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation

ConclusionsThe apixaban and dabigatran trials may be the most representative of hospitalized patients with AF. The DOAC trial results can readily be extrapolated to, and guide prescribing for, at least two thirds of patients discharged from a large metropolitan health service in Australia.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research